The company's lead programs, which are both clinical target ROR1 x B7H3 and EGFT x MUC1. He describes how having two antigens can be beneficial especially in cases where one of the two targets is only modestly express, and he also discusses the difference between AND gating and OR gating.
Coverage brought to you by
Also look for unique social pages for BiotechTV U.
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.
Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.
.png){kind=logo}